- Investing Ideas
- U.K. Pharmaceuticals & Biotech Pure Equity Growth
U.K. Pharmaceuticals & Biotech Pure Equity Growth
Results
9
Companies that has zero debt on their balance sheet and is forecast to grow at an exponential rate in the future.
9 companies
Corcept Therapeutics
Market Cap: US$9.7b
A biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
0I3Q
US$90.84
7D
-1.7%
1Y
24.9%
Camurus
Market Cap: SEK 31.3b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
0RD1
SEK 531.05
7D
-8.0%
1Y
-22.7%
Camurus
Market Cap: SEK 31.3b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMXS
SEK 528.00
7D
-6.4%
1Y
n/a
BioArctic
Market Cap: SEK 27.9b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOABS
SEK 328.70
7D
0%
1Y
n/a
BioArctic
Market Cap: SEK 27.9b
Develops biological drugs for patients with central nervous system disorders in Sweden.
0RV2
SEK 313.07
7D
-3.0%
1Y
67.3%
Bonesupport Holding
Market Cap: SEK 15.2b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
BONEXS
SEK 232.40
7D
1.2%
1Y
-22.1%
Bonesupport Holding
Market Cap: SEK 15.2b
An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.
0RQO
SEK 232.64
7D
-0.5%
1Y
-24.0%
Kuros Biosciences
Market Cap: CHF 824.7m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
0RHR
CHF 20.73
7D
-1.6%
1Y
-27.7%
Kuros Biosciences
Market Cap: CHF 824.7m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURNz
CHF 20.78
7D
5.3%
1Y
-30.8%